Astion Pharma A/S
🇩🇰Denmark
Clinical Trials
17
Active:14
Completed:3
Trial Phases
3 Phases
Phase 1:2
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (40.0%)Phase 2
2 (40.0%)Phase 3
1 (20.0%)Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
Phase 2
Completed
- Conditions
- Discoid Lupus Erythematosus
- Interventions
- Drug: ASF 1096 0.5 % creamDrug: ASF 1096 placebo cream
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2008-02-29
- Lead Sponsor
- Astion Pharma A/S
- Registration Number
- NCT00625157
- Locations
- 🇩🇰
Gregor Jemec, Roskilde Hospital, Denmark
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Phase 2
Completed
- Conditions
- Discoid Lupus Erythematosus
- Interventions
- Drug: Cream vehicle for ASF 1096 cream applied twice dailyDrug: ASF 1096 0.5 % cream applied twice daily
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2008-02-29
- Lead Sponsor
- Astion Pharma A/S
- Target Recruit Count
- 32
- Registration Number
- NCT00625521
- Locations
- 🇸🇪
Filippa Nyberg, Danderyd Stockholm, Sweden
Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis
- First Posted Date
- 2007-11-29
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- Astion Pharma A/S
- Target Recruit Count
- 300
- Registration Number
- NCT00565279
News
No news found